Coronavirus vaccines adapted to the omicron variant will be available in Germany at the earliest in September, Health Minister Karl Lauterbach told the Deutschlandfunk radio station on Thursday (06/09/2022).
The minister explained that there are promising data from the pharmaceutical companies Moderna and BioNtech and that he is confident in the quality of the adapted vaccines.
Moderna presented the first data on the efficacy of its modified vaccine on Wednesday. It is a combination of the original Spikevax vaccine and a candidate vaccine specifically adapted to the omicron variant.
Earlier this month, the European Medicines Agency (EMA) announced that vaccines specifically targeting the omicron variant could receive European Union (EU) approval by the end of September.
Vaccines developed by the American company Moderna and Germany’s BioNtech are the most likely, according to the EMA’s director of vaccine strategy, Marco Cavaleri. He added that the necessary clinical trials are underway and clarified that the EMA is also reviewing the progress of other manufacturers. (dpa)